Overview
Location
Switzerland
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 11, 2026 | Curatis Increases Revenue Growth Guidance for 2026 | Curatis Holding AG (SIX: CURN) increases its revenue growth guidance for the financial year 2026: the company is forecasting a revenue growth of approximately 40% in 2026, in contrast to the previous outlook of over 25%. Based on preliminar... |
| May 28, 2026 | Biotech companies Veraxa and Curatis strengthen financial positions | VERAXA Biotech AG aims to establish the premiere drug discovery and development engine for antibody drug conjugates and other novel antibody-based therapy concepts. The company’s pipeline currently comprises nine discovery and development ... |
| Mar 24, 2026 | Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved | Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of ... |
| Mar 11, 2026 | Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan | Curatis Holding AG (SIX: CURN) and Neupharma Co., Ltd. (“Neupharma”), a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology disorders, today announce an exclusive license and development agreemen... |
| Oct 31, 2025 | More than 20 Swiss biotech companies to exhibit at Bio Europe | Bio-Europe, the leading partnering conference for the global biotechnology industry, is held annually to connect biotech, pharma, investors, and service providers through one-to-one meetings, presentations, and panels. It serves as a leadi... |
| Apr 26, 2024 | Curatis enters SIX Swiss Exchange following the acquisition of Kinarus | |
| Jan 29, 2024 | Kinarus aims to avoid bankruptcy through merger with Curatis | Application has been made to the courts of Basel-Stadt to reverse the bankruptcy of Kinarus Therapeutics Holding AG in Liquidation in order to pursue a Combination Transaction with Curatis AG, a Basel-Landschaft incorporated medicine distr... |
Reviews 0
FAQ about Curatis
What has the press written about Curatis?
Parsers VC has collected 8 articles mentioning Curatis, among them “Curatis Increases Revenue Growth Guidance for 2026” (Jun 11, 2026) and “Biotech companies Veraxa and Curatis strengthen financial positions” (May 28, 2026).
Is Curatis still active?
Yes, Curatis is active; its latest activity on Parsers VC dates from Sep 21, 2026.